CardioMirror: This Smart Mirror Knows Your Pulse, Breathing and Stress Level
Trending Topics Jakob Steinschaden
A smart mirror from FaceHeart reads pulse, breathing and stress in about 40 seconds. It could help spot heart trouble without cuffs, clips or wearables.
Based on reporting by Trending Topics, Jakob Steinschaden — read the original for the full story.
Summary, retelling and take written by AI under human oversight; images are AI-generated illustrations. How we work · Report an error
FaceHeart has put its CardioMirror in front of a live audience at the Taiwan Innotech Expo in Taipei, and the pitch is simple: stand still for about 40 seconds and let a camera do the work. No chest strap. No finger clip. No blood pressure cuff. The mirror watches your face and turns tiny color shifts in the skin into health readings.
Trending Topics tried it at the expo and says the numbers lined up closely with an Oura smart ring on the tester’s finger. Pulse and stress looked fine. Sleep and overall health, less so, which fits the jet lag from Austria to Taiwan. That is a neat demo, but the bigger story is the method underneath it.
FaceHeart builds on remote photoplethysmography, or rPPG, the same basic idea used in pulse oximeters and smartwatches, except here the sensor is just an ordinary camera and ambient light. Software tracks the face, pulls a signal from subtle skin color changes and then uses deep learning to correct for movement and lighting. The company says the same technology is also sold as FaceHeart Vitals through an SDK, a smartphone app and tools for telehealth, wellness and clinical workflows.
The mirror measures heart rate, breathing rate, blood pressure, oxygen saturation, heart rate variability and a stress index. FaceHeart’s bigger bet is heart failure screening. It points to a Journal of Cardiology study in which a 40-second scan reportedly reached an AUC of 0.90 and 89.71 percent accuracy, though the sample was only 68 people. The company also says it can estimate NT-proBNP, a blood marker usually checked with a blood test, and cites a study of 246 people with an AUC of 0.90 and an R² above 0.743.
Regulators have opened one door, not the whole house. FaceHeart says it is the only company worldwide with two FDA clearances for rPPG technology, but those clearances cover pulse rate and respiratory rate only. The heart-failure work and NT-proBNP estimate are still study-backed, not approved. Even so, the company says the system has been tested at Taipei Veterans General Hospital, rural care facilities in Pingtung and, under NDA, the Chang Gung hospital network. It is aiming at waiting rooms, nursing homes, pharmacies and telemedicine, especially where early screening could keep people out of trouble.
My take — AI-written commentary, not fact-checked reporting
This is the kind of health tech that looks gimmicky until it isn’t. FaceHeart is playing the only sensible game in this space: narrow FDA-cleared uses first, then reach for the glamorous stuff like heart-failure screening once the evidence catches up. That’s a better look than the usual miracle-camera nonsense, even if the mirror still feels like something built for a very polite sci-fi hotel.
Read more about this at: Trending Topics